Pearls & Oy-sters: The dangers of PRES: An atypical case with life-threatening presentation

Christina Catherine; Claire Yanta; Aisha R. Saand; Madison Pilato; Sherry H.Y. Chou

doi:10.1212/WNL.0000000000006775

Pearls & Oy-sters: The dangers of PRES: An atypical case with life-threatening presentation

Christina Catherine, Claire Yanta, Aisha R. Saand, Madison Pilato, Sherry H.Y. Chou^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	E282-E285
Journal	Neurology
Volume	92
Issue number	3
DOIs	https://doi.org/10.1212/WNL.0000000000006775
State	Published - Jan 15 2019

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000006775

Cite this

@article{a8aa62e817f04a02b183e3995624d26a,

title = "Pearls & Oy-sters: The dangers of PRES: An atypical case with life-threatening presentation",

author = "Christina Catherine and Claire Yanta and Saand, {Aisha R.} and Madison Pilato and Chou, {Sherry H.Y.}",

note = "Funding Information: C. Catherine, C. Yanta, A. Saand, and M. Pilato report no disclosures relevant to the manuscript. S.H.-Y. Chou is funded by the NIH NINDS K23 award, University of Pittsburgh Development grant, and University of Pittsburgh Physicians Foundation Award, and served as site principal investigator for the NEWTON 2 trial on behalf of Edge Therapeutics. Dr. Chou performed ad hoc consulting services for Edge Therapeutics and Merck Co. Go to Neurology.org/N for full disclosures.",

year = "2019",

month = jan,

day = "15",

doi = "10.1212/WNL.0000000000006775",

language = "English (US)",

volume = "92",

pages = "E282--E285",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Pearls & Oy-sters

T2 - The dangers of PRES: An atypical case with life-threatening presentation

AU - Catherine, Christina

AU - Yanta, Claire

AU - Saand, Aisha R.

AU - Pilato, Madison

AU - Chou, Sherry H.Y.

N1 - Funding Information: C. Catherine, C. Yanta, A. Saand, and M. Pilato report no disclosures relevant to the manuscript. S.H.-Y. Chou is funded by the NIH NINDS K23 award, University of Pittsburgh Development grant, and University of Pittsburgh Physicians Foundation Award, and served as site principal investigator for the NEWTON 2 trial on behalf of Edge Therapeutics. Dr. Chou performed ad hoc consulting services for Edge Therapeutics and Merck Co. Go to Neurology.org/N for full disclosures.

PY - 2019/1/15

Y1 - 2019/1/15

UR - http://www.scopus.com/inward/record.url?scp=85060054599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060054599&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000006775

DO - 10.1212/WNL.0000000000006775

M3 - Comment/debate

C2 - 30643036

AN - SCOPUS:85060054599

SN - 0028-3878

VL - 92

SP - E282-E285

JO - Neurology

JF - Neurology

IS - 3

ER -

Pearls & Oy-sters: The dangers of PRES: An atypical case with life-threatening presentation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this